DE60334094D1 - Verwendung von pleuromutilinen zur behandlung von erkrankungen, die durch helicobacter pylori verursacht werden - Google Patents

Verwendung von pleuromutilinen zur behandlung von erkrankungen, die durch helicobacter pylori verursacht werden

Info

Publication number
DE60334094D1
DE60334094D1 DE60334094T DE60334094T DE60334094D1 DE 60334094 D1 DE60334094 D1 DE 60334094D1 DE 60334094 T DE60334094 T DE 60334094T DE 60334094 T DE60334094 T DE 60334094T DE 60334094 D1 DE60334094 D1 DE 60334094D1
Authority
DE
Germany
Prior art keywords
treatment
helicobacter pylori
utilines
pulley
diseases caused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60334094T
Other languages
English (en)
Inventor
Gerd Ascher
Johannes Hildebrandt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nabriva Therapeutics AG
Original Assignee
Nabriva Therapeutics AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nabriva Therapeutics AG filed Critical Nabriva Therapeutics AG
Application granted granted Critical
Publication of DE60334094D1 publication Critical patent/DE60334094D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60334094T 2002-04-23 2003-04-22 Verwendung von pleuromutilinen zur behandlung von erkrankungen, die durch helicobacter pylori verursacht werden Expired - Lifetime DE60334094D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0209262.5A GB0209262D0 (en) 2002-04-23 2002-04-23 Organic compounds
PCT/EP2003/004173 WO2003090740A1 (en) 2002-04-23 2003-04-22 Use of pleuromutilins for the treatment of disorders caused by helicobacter pylori

Publications (1)

Publication Number Publication Date
DE60334094D1 true DE60334094D1 (de) 2010-10-21

Family

ID=9935350

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60334094T Expired - Lifetime DE60334094D1 (de) 2002-04-23 2003-04-22 Verwendung von pleuromutilinen zur behandlung von erkrankungen, die durch helicobacter pylori verursacht werden

Country Status (12)

Country Link
US (1) US7790749B2 (de)
EP (1) EP1501495B1 (de)
JP (1) JP2005529131A (de)
AT (1) ATE480232T1 (de)
AU (1) AU2003239813A1 (de)
DE (1) DE60334094D1 (de)
ES (1) ES2354972T3 (de)
GB (1) GB0209262D0 (de)
HK (1) HK1073250A1 (de)
SI (1) SI1501495T1 (de)
TW (1) TW200306294A (de)
WO (1) WO2003090740A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0308114D0 (en) * 2003-04-08 2003-05-14 Glaxo Group Ltd Novel compounds
EP2298733B1 (de) * 2005-06-27 2016-05-25 Nabriva Therapeutics AG Pleuromutilinderivate mit einer Hydroxyamino- oder Acyloxyaminocycloalkylgruppe
GB0515995D0 (en) * 2005-08-03 2005-09-07 Sandoz Ag Organic compounds
EP1808431A1 (de) * 2006-01-16 2007-07-18 Nabriva Therapeutics Forschungs GmbH Mutilin Derivate und ihre Verwendung als Arzneimittel
EP1972618A1 (de) 2007-03-20 2008-09-24 Nabriva Therapeutics AG Pleuromutilin-Derivate zur Behandlung von Krankheiten vermittelt durch Mikroben
EP2014645A1 (de) * 2007-07-13 2009-01-14 Nabriva Therapeutics AG Pleuromutilin-derivate und ihre Verwendung als antimikrobielles Wirkungsmittel
EP2159220A1 (de) 2008-09-02 2010-03-03 Nabriva Therapeutics AG Organische Verbindungen
CN102924350B (zh) * 2012-10-31 2014-04-09 中国农业科学院兰州畜牧与兽药研究所 截短侧耳素衍生物及其制备方法和应用
CN103265442B (zh) * 2013-06-05 2017-02-08 北京理工大学 一类新型截短侧耳素衍生物及其制备方法和抗肿瘤用途
TWI762573B (zh) 2017-02-10 2022-05-01 奧地利商納畢瓦治療有限責任公司 截短側耳素之純化

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3560511D1 (en) 1984-02-17 1987-10-01 Sandoz Ag Pleuromutilin derivatives, process for their preparation and their use
CA2042138A1 (en) 1990-04-18 1992-11-09 Hiroo Abe Agents for preventing or treating bacterial diseases of fishes
AUPO758297A0 (en) 1997-06-27 1997-07-24 Rowe, James Baber Control of acidic gut syndrome
GB9918037D0 (en) * 1999-07-30 1999-09-29 Biochemie Gmbh Organic compounds
JP2003529593A (ja) * 2000-04-04 2003-10-07 スミスクライン ビーチャム パブリック リミテッド カンパニー 抗菌剤として用いるための２−ヒドロキシムチリンカルバメート誘導体
DE10030781A1 (de) * 2000-06-29 2002-01-17 Hassan Jomaa Kombinationspräparate von 3-N-Formylhydroxylaminopropylphosphonsäurederivaten oder 3-N-Acetylhydroxylaminopropylphosphonsäurederivaten mit spezielen pharmazeutischen Wirkstoffen
GB0017031D0 (en) * 2000-07-11 2000-08-30 Biochemie Gmbh Antimicrobials
PE20020676A1 (es) 2000-09-13 2002-08-27 Biochemie Gmbh Compuestos de mutilina como antibacterianos
GB0024811D0 (en) * 2000-10-10 2000-11-22 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
TW200306294A (en) 2003-11-16
EP1501495A1 (de) 2005-02-02
ES2354972T3 (es) 2011-03-21
AU2003239813A1 (en) 2003-11-10
HK1073250A1 (en) 2005-09-30
GB0209262D0 (en) 2002-06-05
US7790749B2 (en) 2010-09-07
JP2005529131A (ja) 2005-09-29
WO2003090740A1 (en) 2003-11-06
EP1501495B1 (de) 2010-09-08
ATE480232T1 (de) 2010-09-15
SI1501495T1 (sl) 2011-01-31
US20050131023A1 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
DE60215787D1 (de) Behandlung von typ ii diabetes mit dipeptidyl-peptidase-iv-hemmern
PL374865A1 (en) Treatment of tnf alpha related disorders
DE60312309D1 (de) Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten
HK1073250A1 (en) Use of pleuromutilins for the treatment of disorders caused by helicobacter pylori
ATE411399T1 (de) Behandlung der huntington's krankheit mit epa
EA200401525A1 (ru) Способы лечения гепатита (варианты )
DE60327557D1 (de) Verwendung von spongosin (2-methoxyadenosin) zur behandlung von schmerzen, insbesondere hyperalgesie
BR0308813A (pt) Tratamento de tuberculose usando derivados de pleuromutilina
ATE331527T1 (de) Verfahren zur behandlung von brustdrüsenerkrankungen
DE602004022285D1 (de) Verfahren zur behandlung von erkrankungen mit hsp90-hemmenden mitteln in kombination mit antimitotika
DE60310400D1 (de) Botulinustoxine zur behandlung von priapismus
PL371205A1 (en) Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
ATE473277T1 (de) Zusammensetzungen und verfahren zur prävention und behandlung von immunvermittelten entzündungskrankheiten
DE60308045D1 (de) Pflanzenextrakte aus argyrolobium roseum zur behandlung von diabetes
ATE502637T1 (de) Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum
DE602004016126D1 (de) Aplidine zur behandlung von multiplem myelom
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
SE0301883D0 (sv) New use II
ATE392212T1 (de) Verwendung eines proteasom-inhibitors zur behandlung fibrotischer erkrankungen
ATE497003T1 (de) Pharmazeutische zusammensetzung zur herstellung eines medikaments zur behandlung und/oder vorbeugung einer pathologie die mit einer obsessiven störung und/oder fettleibigkeit im zusammenhang steht
SE0301884D0 (sv) New use III
ATE460168T1 (de) Nicht-radioaktives strontiummittel zur behandlung von krebs
ATE431157T1 (de) Verfahren zur behandlung von durch taxol induzierter sensorischer neuropathie
ATE486594T1 (de) Methode zur behandlung von herzinsuffizienz
NZ516651A (en) 17-beta-decanoate-4estrene-3-one and 17-beta-cyclohexylpropionate-4-estrene-3-one for treating aggression and stimulating appetite in stags (deer) during puberty especially for promoting and obtaining stag's horn